一个开放的随机对照试验的 leflunomide 在急性SARS-CoV-2 omicron变体感染的患者
Zhou Pan1, Zhihui Wan2, Yixuan Wang1
1Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
Frontiers in medicine
|August 3, 2023
概括
对急性COVID-19的leflunomide治疗减少了患者的发烧和病毒泄漏时间. 然而,在本研究中,它并没有显著缩短持续临床康复的时间.
科学领域:
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由SARS-CoV-2引起的COVID-19大流行需要探索新的治疗策略.
- 一种免疫调节药物莱夫卢诺胺具有潜在的抗病毒性质,需要对COVID-19治疗进行调查.
研究的目的:
- 评估 leflunomide 作为治疗急性,症状性 COVID-19 的疗效和安全性.
- 评估莱夫卢诺米德对发烧持续时间,病毒分泌和临床康复时间的影响.
主要方法:
- 一个单中心,开放标签,随机对照试验与有症状的COVID-19患者进行.
- 患者接受了莱夫卢诺胺加上症状治疗或仅仅症状治疗5天.
- 主要终点是持续临床康复的时间.
主要成果:
- 勒弗卢诺米德治疗显著减少了发烧持续时间 (p=0.027) 和病毒分泌时间 (p=0.044).
- 在莱夫卢诺胺和对照组之间持续临床康复的时间没有显著差异 (p=0.207).
- 57名参与者被随机分配,其中27人在莱夫卢诺胺组,30人在对照组.
结论:
- 勒弗卢诺米德与症状治疗相结合,有效地减少了急性COVID-19患者的发烧持续时间和病毒泄漏.
- 勒弗卢诺胺在加速急性COVID-19持续临床康复方面没有显著的益处.
相关概念视频
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Antiasthma Drugs: Leukotriene Modifiers
361
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
361
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
153
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
153
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K


